Original language | English |
---|---|
Journal | Lancet |
DOIs | |
Publication status | Published - 2013 |
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial.
Research output: Contribution to journal › Article › peer-review